Function
Locations
First committed cytosolic step: condenses acetoacetyl-CoA + acetyl-CoA to HMG-CoA (SREBP-regulated). Distinct from mitochondrial HMGCS2 of ketogenesis.
The mevalonate pathway is the cytosolic/ER route that converts acetyl-CoA into the universal five-carbon isoprenoid building block isopentenyl diphosphate (IPP), the precursor of cholesterol, dolichol, ubiquinone (CoQ), heme A, and the farnesyl/ geranylgeranyl groups used for protein prenylation. Cytosolic HMG-CoA synthase (HMGCS1) condenses acetoacetyl-CoA with acetyl-CoA to 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA); HMG-CoA reductase (HMGCR), the rate-limiting, committed, sterol-feedback-regulated enzyme and target of the statin drugs, reduces HMG-CoA to mevalonate using 2 NADPH on the endoplasmic-reticulum membrane; mevalonate kinase (MVK) and phosphomevalonate kinase (PMVK) then doubly phosphorylate mevalonate to mevalonate-5-diphosphate; and diphosphomevalonate decarboxylase (MVD) decarboxylates it to IPP. Inherited defects cause: mevalonate kinase deficiency (MVK) — spanning hyper-IgD/periodic fever syndrome to mevalonic aciduria; porokeratosis (MVD and MVK); and HMGCR/HMGCS1 are pharmacologic/ autoimmune (statin) and rare-myopathy loci rather than classic enzymopathies.
All recommended fields populated.
✗ none found
No MODULE:mevalonate_pathway deep-research report alongside the module YAML.
✓ every leaf node grounds to a representative protein.
✓ every declared conforms_to bundle matches its template motif.
5 complete review(s) · 0 with deep research · 0 missing review · 5 reviewed but lacking deep research
| Gene | Review | Complete | Deep research |
|---|---|---|---|
| HMGCR P04035 | ✓ | ✓ | ✗ |
| HMGCS1 Q01581 | ✓ | ✓ | ✗ |
| MVD P53602 | ✓ | ✓ | ✗ |
| MVK Q03426 | ✓ | ✓ | ✗ |
| PMVK Q15126 | ✓ | ✓ | ✗ |
The mevalonate pathway (acetyl-CoA -> IPP) grounded to the human enzymes HMGCS1 (UniProtKB:Q01581, GO:0004421, EC 2.3.3.10), HMGCR (P04035, GO:0004420, EC 1.1.1.34), MVK (Q03426, GO:0004496, EC 2.7.1.36), PMVK (Q15126, GO:0004631, EC 2.7.4.2) and MVD (P53602, GO:0004163, EC 4.1.1.33). GO molecular-function terms were taken from the human GOA records; Reactome reaction ids and titles were verified against the local reactome cache. Each step uses a PANTHER family selector (generic over orthologs; HMGCS node covers HMGCS1 cytosolic + HMGCS2 mitochondrial, the latter being the ketogenesis enzyme reviewed in the ketogenesis module). HMGCR is the sole ER-membrane step (sterol-regulated, statin target); the rest are cytosolic. Downstream, IPP is isomerised to dimethylallyl-PP (IDI1) and condensed by farnesyl/geranylgeranyl-PP synthases (FDPS/GGPS1) toward squalene -> cholesterol (post-squalene sterol synthesis: SQLE/LSS/.../SC5D/DHCR7/DHCR24), and also supplies dolichol, ubiquinone (CoQ), heme A and the prenyl groups for protein prenylation. Disorders: MVK -> mevalonate kinase deficiency (HIDS/periodic fever to mevalonic aciduria); MVD (and MVK) -> porokeratosis; HMGCR -> statin target and autoantibody-mediated necrotizing myopathy; HMGCS1 -> a rare rigid-spine myopathy. (Acetoacetyl-CoA for HMGCS1 is supplied by cytosolic thiolase ACAT2.)
First committed cytosolic step: condenses acetoacetyl-CoA + acetyl-CoA to HMG-CoA (SREBP-regulated). Distinct from mitochondrial HMGCS2 of ketogenesis.
Rate-limiting, committed enzyme of the pathway; polytopic ER-membrane protein with sterol-sensing domain and SREBP/Insig-regulated degradation. Target of the statin cholesterol-lowering drugs.
Phosphorylates mevalonate to mevalonate-5-phosphate. Deficiency causes mevalonate kinase deficiency (hyper-IgD/periodic fever to mevalonic aciduria).
Phosphorylates mevalonate-5-phosphate to mevalonate-5-diphosphate (between MVK and MVD).
Final step: ATP-dependent decarboxylation of mevalonate-5-diphosphate to the C5 isoprenoid unit isopentenyl diphosphate (IPP). Deficiency causes porokeratosis.